Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Receives Consensus Rating of Buy from Brokerages

Shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD – Get Free Report) have been assigned an average rating of “Buy” from the six ratings firms that are covering the company, Marketbeat reports. Six analysts have rated the stock with a buy recommendation. The average 1 year target price among analysts that have issued ratings on the […]

Related Keywords

Canada ,Robert Barrow ,Dan Karlin ,Leerink Partnrs ,Royal Bank ,Nasdaq ,Jump Financial ,Securities Exchange Commission ,Regal Investment Advisors ,Sequoia Financial Advisors ,Medicine Mindmed Inc ,Commonwealth Equity Services ,Bailard Inc ,Mind Medicine ,Get Free Report ,Exchange Commission ,Investment Advisors ,Equity Services ,Get Free ,Mind Medicine Mindmed ,Nasdaq Mnmd ,Mnmd ,Medical ,Ratings ,Consensus ,